Neurological signs and the heterogeneity of schizophrenia

American Journal of Psychiatry

Volumn 157, Issue 4, 2000, Pages 560-565

  Arango, Celso ^b   Kirkpatrick, Brian ^a   Buchanan, Robert W ^b  

^a MPRC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DELUSION; DEMOGRAPHY; DISORIENTATION; FEMALE; GENETIC HETEROGENEITY; HALLUCINATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NEUROPATHOLOGY; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA;

ADULT; AMBULATORY CARE; BIOLOGICAL MARKERS; BRIEF PSYCHIATRIC RATING SCALE; DELUSIONS; FEMALE; HALLUCINATIONS; HUMANS; MALE; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR DISORDERS; PSYCHOMOTOR PERFORMANCE; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0034073101     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.4.560     Document Type: Article

References (56)

1. Arndt S, Alliger RJ, Andreasen NC: The distinction of positive and negative symptoms: the failure of a two-dimensional model. Br J Psychiatry 1991; 158:317-322
2. Buchanan RW, Carpenter WT Jr: Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia. J Nerv Ment Dis 1994; 182:193-204
3. Liddle PF: Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 1987; 17:49-57
4. Peralta V, de Leon J, Cuesta MJ: Are there more than two syndromes in schizophrenia? a critique of the positive-negative dichotomy. Br J Psychiatry 1992; 161:335-343
5. Heinrichs DW, Buchanan RW: Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 1988; 145:11-18
6. Buchanan RW, Heinrichs DW: The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 1989; 27: 335-350
7. Merriam AE, Kay SR, Opler LA, Kushner SF, van Praag HM: Neurological signs and the positive-negative dimension in schizophrenia. Biol Psychiatry 1990; 28:181-192
8. Flashman LA, Flaum M, Gupta S, Andreasen NC: Soft signs and neuropsychological performance in schizophrenia. Am J Psychiatry 1996; 153:526-532
9. Wong AH, Voruganti LN, Heslegrave RJ, Awad AG: Neurocognitive deficits and neurological signs in schizophrenia. Schizophr Res 1997; 23:139-146
10. Manschreck TC, Maher BA, Rucklos ME, Vereen DR: Disturbed voluntary motor activity in schizophrenic disorder. Psychol Med 1982; 12:73-84
11. Rochford JM, Detre T, Tucker GJ, Harrow M: Neuropsychological impairments in functional psychiatric diseases. Arch Gen Psychiatry 1970; 22:114-119
12. King DJ, Wilson A, Cooper SJ, Waddington JL: The clinical correlates of neurological soft signs in chronic schizophrenia. Br J Psychiatry 1991; 158:770-775
13. Mohr F, Hubmann W, Cohen R, Bender W, Haslacher C, Honicke S, Schlenker R, Wahlheim C, Werther P: Neurological soft signs in schizophrenia: assessment and correlates. Eur Arch Psychiatry Clin Neurosci 1996; 246:240-248
14. Nasrallah HA, Tippin J, McCalley-Whitters M, Kuperman S: Neurological differences between paranoid and nonparanoid schizophrenia, part III: neurological soft signs. J Clin Psychiatry 1982; 43:310-312
15. Manschreck TC, Ames D: Neurologic features and psychopathology in schizophrenic disorders. Biol Psychiatry 1984; 19: 703-719
16. Kolakowska T, Williams AO, Jambor K, Ardern M: Schizophrenia with good and poor outcome, III: neurological "soft" signs, cognitive impairment and their clinical significance. Br J Psychiatry 1985; 146:348-357
17. Gureje O: Correlates of positive and negative schizophrenic syndromes in Nigerian patients. Br J Psychiatry 1989; 155: 628-632
18. Chen EY, Lam LC, Chen RY, Nguyen DG: Negative symptoms, neurological signs and neuropsychological impairments in 204 Hong Kong Chinese patients with schizophrenia. Br J Psychiatry 1996; 168:227-233
19. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT Jr: Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry 1990; 147:290-294
20. Liddle PF: The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br J Psychiatry 1987; 151:145-151
21. Schroder J, Niethammer R, Geider FJ, Reitz C, Binkert M, Jauss M, Sauer H: Neurological soft signs in schizophrenia. Schizophr Res 1991; 6:25-30
22. Schroder J, Buchsbaum MS, Siegel BV, Geider FJ, Niethammer R: Structural and functional correlates of subsyndromes in schizophrenia. Psychopathology 1995; 28:38-45
23. Davis JM: Comparative doses and costs of antipsychotic medication. Arch Gen Psychiatry 1976; 33:858-861
24. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
25. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr: The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Res 1989; 30:119-123
26. Carpenter WT Jr, Heinrichs DW, Wagman AM: Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988; 145:578-583
27. Fenton WS, McGlashan TH: Testing systems for assessment of negative symptoms in schizophrenia. Arch Gen Psychiatry 1992; 49:179-184
28. Amador XF, Kirkpatrick B, Buchanan RW, Carpenter WT, Marcinko L, Yale SA: Stability of the diagnosis of deficit syndrome in schizophrenia. Am J Psychiatry 1999; 156:637-639
29. Hollingshead AB, Redlich FC: Social Class and Mental Illness: A Community Study. New York, John Wiley & Sons, 1958
30. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT: Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49:522-530
31. Kirkpatrick B, Amador XF, Flaum M, Yale SA, Gorman JM, Carpenter WT Jr, Tohen M, McGlashan T: The deficit syndrome in the DSM-IV Field Trial, I: alcohol and other drug abuse. Schizophr Res 1996; 20:69-77
32. Kirkpatrick B, Ram R, Amador XF, Buchanan RW, McGlashan T, Tohen M, Bromet E: Summer birth and the deficit syndrome of schizophrenia. Am J Psychiatry 1998; 155:1221-1226
33. Arango C, Adami H, Sherr JD, Thaker GK, Carpenter WT Jr: Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness. Am J Psychiatry 1999; 156:1097-1099
34. Kirkpatrick B, Castle D, Murray RM, Carpenter WT Jr: Risk factors for the deficit syndrome of schizophrenia. Schizophr Bull (in press)
35. Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT Jr: Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry 1994; 51:804-811
36. Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT Jr: Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 1993; 150:59-65
37. Buchanan RW, Breier A, Kirkpatrick B, Ball P, Carpenter WT Jr: Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry 1998; 155:751-760
38. Bustillo JR, Thaker G, Buchanan RW, Moran M, Kirkpatrick B, Carpenter WT Jr: Visual information-processing impairments in deficit and nondeficit schizophrenia. Am J Psychiatry 1997; 154:647-654
39. Carpenter WT Jr: The treatment of negative symptoms: pharmacological and methodological issues. Br J Psychiatry Suppl 1996; 29:17-22
40. Fenton WS, McGlashan TH: Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am J Psychiatry 1994; 151:351-356
41. Fenton WS, Wyatt RJ, McGlashan TH: Risk factors for spontaneous dyskinesia in schizophrenia. Arch Gen Psychiatry 1994; 51:643-650
42. Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT Jr: Case identification and stability of the deficit syndrome of schizophrenia. Psychiatr Res 1993; 47:47-56
43. Kirkpatrick B, Buchanan RW, Breier A, Carpenter WT Jr: Depressive symptoms and the deficit syndrome of schizophrenia. J Nerv Ment Dis 1994; 182:452-455
44. Kirkpatrick B, Amador XF, Yale SA, Bustillo JR, Buchanan RW, Tohen M: The deficit syndrome in the DSM-IV Field Trial, part II: depressive episodes and persecutory beliefs. Schizophr Res 1996; 20:79-90
45. Kopelowicz A, Liberman RP, Mintz J, Zarate R: Comparison of efficacy of social skills training for deficit and nondeficit negative symptoms in schizophrenia. Am J Psychiatry 1997; 154: 424-425
46. Ribeyre JM, Lesieur P, Varoquaux O, Dollfus S, Pays M, Petit M: A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia. Biol Psychiatry 1994; 36:230-236
47. Ross DE, Thaker GK, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Moran M, Hartley J: Association of abnormal smooth pursuit eye movement with the deficit syndrome in schizophrenic patients. Am J Psychiatry 1996; 153:1158-1165
48. Waltrip RW II, Buchanan RW, Carpenter WT Jr, Kirkpatrick B, Summerfelt A, Breier A, Rubin SA, Carbone KM: Borna disease virus antibodies and the deficit syndrome of schizophrenia. Schizophr Res 1997; 23:253-257
49. Van der Does AJ, Dingemans PM, Linszen DH, Nugter MA, Scholte WF: Symptom dimensions and cognitive and social functioning in recent-onset schizophrenia. Psychol Med 1993; 23:745-753
50. Gureje O, Aderibigbe YA, Obikoya O: Three syndromes in schizophrenia: validity in young patients with recent onset of illness. Psychol Med 1995; 25:715-725
51. Rowe EW, Shean G: Card-sort performance and syndromes of schizophrenia. Genet Soc Gen Psychol Monogr 1997; 123: 197-209
52. Chapman LJ, Chapman JP: The measurement of differential deficit. J Psychiatr Res 1978; 14:303-311
53. Malla AK, Norman RM, Aguilar O, Cortese L: Relationship between neurological "soft signs" and syndromes of schizophrenia. Acta Psychiatr Scand 1997; 96:274-280
54. Sanders RD, Keshavan MS, Schooler NR: Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am J Psychiatry 1994; 151:1231-1233
55. Peralta V, Cuesta MJ, Farre C: Factor structure of symptoms in functional psychoses. Biol Psychiatry 1997; 42:806-815
56. Ratakonda S, Gorman JM, Yale SA, Amador XF: Characterization of psychotic conditions: use of the domains of psychopathology model. Arch Gen Psychiatry 1998; 55:75-81